[1]
Rashid, L. 2025. Treatment-resistant hypophosphataemia after ferric carboxymaltose: expanding the spectrum of 6H syndrome (hypophosphataemia, hyperphosphaturia, hypovitaminosis D, hypocalcaemia, secondary hyperparathyroidism, high fibroblast growth factor-23). European Journal of Case Reports in Internal Medicine. 12, 11 (Oct. 2025). DOI:https://doi.org/10.12890/2025_005824.